InvestorsHub Logo

To infinity and beyond!

01/21/21 9:50 AM

#340914 RE: BonelessCat #340900

So we disagree. As a shareholder I find his comments way out of line and pointless and stupid. I was sorry to read it and sorry he sent it.

Maybe you would enjoy reading back over the big market app for an oral psoriasis drug? Can you say Prurisol?

Maybe some commentary about how many people die every day from cancer, and how much trouble P53 drugs have had? How about Kevetrin and that big opportunity?

Pathetic: wannabe COVID therapy- do your successful trial and we can talk later, Leo/IP.

loanranger

01/21/21 10:02 AM

#340923 RE: BonelessCat #340900

"It wasn’t a PR, it didn’t claim anything."
That's for sure. It was just a message directed to an audience that was already well aware of its contents.

To paraphrase:
Bad stuff is happening every day.
Vaccines don't fix sick people.
There's gonna be a B-Covid P2 trial someday.


A Shareholder Alert.
Kind of like the Network's "Breaking News".
Not Breaking and Not News.


Not saying it's a bad thing, or even "fluff". And it didn't cost much, so what's the harm?


Maybe it was Locust Walk's idea.